Mometasone Furoate
Brand Names: Allergy Relief, Allergy, Sinuva, Nasonex, Childrens Nasonex, Asmanex Hfa
Methodology & AI Transparency ⓘ
Mometasone Furoate Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Mometasone furoate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and pediatric patients 2 years of age and older.
- 2 Real-world patient consensus: Real-world cohort score of 76% across 15 de-identified Mometasone Furoate entries.
- 3 Typical cash cost range: Dispensing cost comparison spans $12.88 mail/discount cash up to $34.88 uninsured retail (federal NADAC $0.2029).
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Mometasone Furoate): pruritus (4.7%), nausea (9.4%), headache (7.5%).
Ask our AI Specialists anything about Mometasone Furoate
Mometasone Furoate Mechanism, CYP450 Pathways & DailyMed Monograph
Mometasone furoate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and pediatric patients 2 years of age and older. ( 1 ) Mometasone furoate ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and pediatric patients 2 years of age or older.
12.1 Mechanism of Action Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in dermatoses is unknown.
Systemic exposure to Mometasone Furoate reflects Consistent 54%–66% gastrointestinal absorption profile for Mometasone Furoate absorption kinetics and systemic clearance of mometasone furoate integrates hepatic phase ii conjugation with renal filtration, sustaining receptor engagement across a Elimination kinetics span 11 to 16 hours per Mometasone Furoate clinical pharmacology half-life window (cmax attained 2–5 hours post-administration of mometasone furoate response profile).
Dosing protocols (50 ug/1 Spray, Metered or 1350 ug/1 Implant or 1 mg/g Cream or 1 mg/g Ointment or 200 ug/1 Aerosol) balance efficacy (76.00% patient satisfaction across 15 logs) against nausea (9.4% of reports), headache (7.5% of reports), dizziness (6.4% of reports), with strict avoidance in mometasone furoate ointment is contraindicated in patients with a history of hypersensitivity to mometasone furoate or any of the excipients in mometasone furoate ointment.; ( 4 ) mometasone furoate ointment is contraindicated in patients with a history of hypersensitivity to mometasone furoate or any of the excipients in mometasone furoate ointment..
Verify medication reconciliation lists so Mometasone Furoate is not inadvertently duplicated with another corticosteroid.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Mometasone Furoate dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Mometasone furoate ointment is contraindicated in patients with a history of hypersensitivity to mometasone furoate or any of the excipients in mometasone furoate ointment.
- ( 4 ) Mometasone furoate ointment is contraindicated in patients with a history of hypersensitivity to mometasone furoate or any of the excipients in mometasone furoate ointment.
Logged Side-Effect Incidence (15 Reports)
Mometasone Furoate Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Mometasone Furoate)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately: What a 3,065-Participant Study Found MF/IND/GLY showed improvement in lung function and reduction in asthma exacerbations over MF/IND and FLU/SAL independent of baseline eosinophil levels, indicating that eosinophil levels did not affect the efficacy of... Respiratory medicine • 2023-10-15 • Phase III Randomized Trial | N = 3,065 | 90/100 | PMID 37392789 ↗ |
| Can This Approach Help? Inside the Latest Research on Once-daily, single-inhaler indacaterol/mometasone versus twice-daily Once-daily, single-inhaler IND/MF high-dose improved lung function with better asthma control, reduced asthma exacerbations with comparable safety versus twice-daily SAL/FLU high-dose. The Journal of asthma : official journal of the Association for the Care of Asthma • 2022-08-15 • Phase III Randomized Trial | N = 107 | 88/100 | PMID 34346266 ↗ |
| Can This Approach Help? Inside the Latest Research on Phase 3b randomized controlled trial of fevipiprant in patients with nasal THUNDER provided no evidence of a role for fevipiprant in the treatment of patients with CRSwNP and asthma; future studies may establish a role for other DP 2 antagonists, specifically in patients with aspirin-exacerbated... The Journal of allergy and clinical immunology • 2022-05-15 • Phase III Randomized Trial | N = 32 | 88/100 | PMID 35094848 ↗ |
Mometasone Furoate Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.2029/unit (~$6.09/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $12.88 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.88 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 15 Anonymous DotMD Community Micro-Logs | $14.81 / mo | View logs ↓ |
Mometasone Furoate Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Mometasone Furoate RxNorm Concept ID | 151029 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.2029 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.88 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $12.88 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 76.00% Worth It (15 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Mometasone Furoate Patient Community, Cohort Filters & Dosage Logs
Deterministic Mometasone Furoate reference combining NIH RxNorm (151029), Medicaid NADAC ($0.2029/unit), and anonymous cohort outcomes (76% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Mometasone Furoate community threads and patient logs by age, biological sex, dosage, and treatment duration.